The primary endpoint of this study was to investigate whether hANP can prevent the occurrence of AKI during cardiac surgery, and the mechanisms of the renoprotective effects of hANP, with emphasis on the intrarenal RAAS, using NGAL and L-FABP as the biomarkers of AKI. Here, LCN2 is linked to acute kidney injury.